LiveActive security incident?Get immediate response
CVE Record

CVE-2024-0758: MolecularFaces XSS

MolecularFaces before 0.3.0 is vulnerable to cross site scripting. A remote attacker can execute arbitrary JavaScript in the context of a victim browser via crafted molfiles.

MediumCVSS 6.1Not KEV-listedUpdated
Glexia's TakeAutomated analysismoderate

Security readout for executives and security teams

Plain-English summary

CVE-2024-0758 is a cross-site scripting issue in MolecularFaces before 0.3.0. If a user opens or views a malicious molfile through an affected application, attacker-supplied JavaScript may run in that user's browser context. Business urgency is moderate unless the software processes untrusted molfiles or is exposed to external users.

Executive priority

Treat this as a moderate-priority application security fix. It is not marked as exploited in the provided sources, but it can affect user trust and session integrity where MolecularFaces handles untrusted chemistry files.

Technical view

The issue is CWE-79 XSS in de.ipb-halle:molecularfaces, triggered through crafted molfiles. The CVSS 3.1 score is 6.1 with network attack vector, low complexity, no privileges required, required user interaction, changed scope, and low confidentiality and integrity impact. Availability impact is not identified.

Likely exposure

Exposure is likely limited to applications that depend on MolecularFaces before 0.3.0 and render or process molfiles supplied by users, partners, researchers, or external systems. The affected-version data in the bundle is sparse, so confirm package coordinates and deployed versions directly.

Exploitation context

The source bundle does not cite active exploitation, and CISA KEV status is false. Exploitation requires a victim interaction with a crafted molfile. The realistic risk is browser-side script execution leading to session abuse, content tampering, or data exposure within the affected application's trust context.

Researcher notes

Key evidence is consistent on XSS via crafted molfiles in MolecularFaces before 0.3.0. The affected product metadata lists limited version detail, so validation should rely on package inventory and the upstream GHSA. Do not assume broader products are affected without dependency evidence.

Mitigation direction

  • Upgrade MolecularFaces to 0.3.0 or later where applicable.
  • Review the GitHub advisory for vendor-confirmed remediation details.
  • Limit handling of untrusted molfiles until affected deployments are updated.
  • Prioritize internet-facing or collaborative molfile workflows first.

Validation and detection

  • Inventory applications using de.ipb-halle:molecularfaces.
  • Check lockfiles, build manifests, and SBOMs for versions before 0.3.0.
  • Identify features that render or preview user-supplied molfiles.
  • Confirm molfile rendering is sanitized or encoded after remediation.
  • Verify SCA tools no longer flag GHSA-2pwh-52h7-7j84.
Prepared
Confidence
high
Sources
5

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cwe · medium confidence lookup

CWE-79: User-session and phishing behavior lookup

Client-side and session-facing weaknesses should be reviewed alongside initial-access and user-execution behaviors. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2024-0758 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Medium
CVSS
6.1 (3.1)
Known Exploited
No
Published

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

1CVSS vectors
3Timeline events
2ADP providers
4Source links

SSVC decision data

CISA-ADPCISA Coordinator
Timestamp
Version
2.0.3
Exploitation: noneAutomatable: noTechnical Impact: partial

CVSS vector scores

1 official score

We collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.

ScoreVersionSeverityVectorExploitImpactSource
6.1CVSS 3.1MediumCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N2.82.7CISA-ADP

Vulnerability scoring details

Base CVSS 3.1 score

6.1Medium
CVSS 3.1 vector shape for CVE-2024-0758Attack VectorAttack ComplexityPrivileges RequiredUser InteractionScopeConfidentiality ImpactIntegrity ImpactAvailability Impact

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Attack Vector
NetworkAdjacentLocalPhysical
Attack Complexity
LowHigh
Privileges Required
NoneLowHigh
User Interaction
NoneRequired
Scope
ChangedUnchanged
Confidentiality Impact
HighLowNone
Integrity Impact
HighLowNone
Availability Impact
HighLowNone

Vulnerability timeline

Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.

  1. CVE reservedCVE Program

    The CVE ID was reserved by the assigning CNA.

  2. CVE publishedCVE Program

    The CVE record was published.

  3. CVE updatedCVE Program

    The CVE record metadata indicates this as the latest update time.

ADP provider summaries

CVECVE Program Container
CISA-ADPCISA ADP Vulnrichment
cvssV3_1other:ssvc

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
Unknown vendorde.ipb-halle:molecularfacesde.ipb-halle:molecularfaces, 0unaffected
Weakness

CWE details

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.

CWE-79 · source CWE mapping

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.